Literature DB >> 28879548

Cepharanthine Inhibits IFN-γ-Induced CXCL10 by Suppressing the JAK2/STAT1 Signal Pathway in Human Salivary Gland Ductal Cells.

Keiko Aota1, Tomoko Yamanoi2, Koichi Kani2, Masayuki Azuma2.   

Abstract

Cepharanthine, a biscolaurine alkaloid isolated from the plant Stephania cephalantha Hayata, has been reported to have potent anti-inflammatory properties. Here, we investigated the effects of cepharanthine on the expression of CXCL10 (a CXC chemokine induced by interferon-gamma [IFN-γ] that has been observed in a wide variety of chronic inflammatory disorders and autoimmune conditions) in IFN-γ-treated human salivary gland cell lines. We observed that IFN-γ-induced CXCL10 production in NS-SV-DC cells (a human salivary gland ductal cell line), but not in NS-SV-AC cells (a human salivary gland acinar cell line). Cepharanthine inhibited the IFN-γ-induced CXCL10 production in NS-SV-DC cells. A Western blot analysis showed that cepharanthine prevented the phosphorylation of JAK2 and STAT1, but did not interfere with the NF-κB pathway. Moreover, cepharanthine inhibited the IFN-γ-mediated chemotaxis of Jurkat T cells. These results suggest that cepharanthine suppresses IFN-γ-induced CXCL10 production via the inhibition of the JAK2/STAT1 signaling pathway in human salivary gland ductal cells. Our findings also indicate that cepharanthine could inhibit the chemotaxis of Jurkat T cells by reducing CXCL10 production.

Entities:  

Keywords:  CXCL10; IFN-γ; JAK/STAT1 signaling; cepharanthine; primary Sjögren’s syndrome; salivary gland ductal cells

Mesh:

Substances:

Year:  2018        PMID: 28879548     DOI: 10.1007/s10753-017-0662-x

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  Role of cytokines in the destruction of acinar structure in Sjögren's syndrome salivary glands.

Authors:  M Azuma; K Motegi; K Aota; Y Hayashi; M Sato
Journal:  Lab Invest       Date:  1997-09       Impact factor: 5.662

2.  Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins.

Authors:  A D Luster; J C Unkeless; J V Ravetch
Journal:  Nature       Date:  1985 Jun 20-26       Impact factor: 49.962

3.  The identification and characterization of a STAT 1 binding site in the PPARgamma2 promoter.

Authors:  J C Hogan; J M Stephens
Journal:  Biochem Biophys Res Commun       Date:  2001-09-21       Impact factor: 3.575

4.  Expressions of cytokine genes during development of autoimmune sialadenitis in MRL/lpr mice.

Authors:  H Hamano; I Saito; N Haneji; Y Mitsuhashi; N Miyasaka; Y Hayashi
Journal:  Eur J Immunol       Date:  1993-10       Impact factor: 5.532

5.  Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.

Authors:  Noriyoshi Ogawa; Li Ping; Li Zhenjun; Yukiko Takada; Susumu Sugai
Journal:  Arthritis Rheum       Date:  2002-10

6.  Cepharanthin, a biscoclaurine alkaloid, prevents destruction of acinar tissues in murine Sjögren's syndrome.

Authors:  Masayuki Azuma; Yuki Ashida; Tetsuya Tamatani; Katsumi Motegi; Natsumi Takamaru; Naozumi Ishimaru; Yoshio Hayashi; Mitsunobu Sato
Journal:  J Rheumatol       Date:  2006-05       Impact factor: 4.666

7.  Immortalization of normal human salivary gland cells with duct-, myoepithelial-, acinar-, or squamous phenotype by transfection with SV40 ori- mutant deoxyribonucleic acid.

Authors:  M Azuma; T Tamatani; Y Kasai; M Sato
Journal:  Lab Invest       Date:  1993-07       Impact factor: 5.662

8.  Lymphotactin: a cytokine that represents a new class of chemokine.

Authors:  G S Kelner; J Kennedy; K B Bacon; S Kleyensteuber; D A Largaespada; N A Jenkins; N G Copeland; J F Bazan; K W Moore; T J Schall
Journal:  Science       Date:  1994-11-25       Impact factor: 47.728

9.  Recombinant leukocyte A interferon: pharmacokinetics, single-dose tolerance, and biologic effects in cancer patients.

Authors:  J U Gutterman; S Fine; J Quesada; S J Horning; J F Levine; R Alexanian; L Bernhardt; M Kramer; H Spiegel; W Colburn; P Trown; T Merigan; Z Dziewanowski
Journal:  Ann Intern Med       Date:  1982-05       Impact factor: 25.391

10.  Essential involvement of cross-talk between IFN-gamma and TNF-alpha in CXCL10 production in human THP-1 monocytes.

Authors:  Xu-Feng Qi; Dong-Heui Kim; Yang-Suk Yoon; Dan Jin; Xue-Zhu Huang; Jian-Hong Li; Young-Kun Deung; Kyu-Jae Lee
Journal:  J Cell Physiol       Date:  2009-09       Impact factor: 6.384

View more
  4 in total

1.  Downregulation of MYO1C mediated by cepharanthine inhibits autophagosome-lysosome fusion through blockade of the F-actin network.

Authors:  Yanhao Zhang; Xiuxing Jiang; Qin Deng; Ziyi Gao; Xiangyu Tang; Ruoqiu Fu; Jinjiao Hu; Yunong Li; Lirong Li; Ning Gao
Journal:  J Exp Clin Cancer Res       Date:  2019-11-07

Review 2.  Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.

Authors:  Christian Bailly
Journal:  Phytomedicine       Date:  2019-05-10       Impact factor: 5.340

3.  Potential Mechanisms of White Peony against Primary Sjögren's Syndrome Based on Network Pharmacology and Molecular Docking.

Authors:  Shuqi Zhuang; Jincheng Pu; Yuanyuan Liang; Zhenzhen Wu; Ronglin Gao; Shengnan Pan; Jiamin Song; Jianping Tang; Xuan Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-12       Impact factor: 2.650

Review 4.  A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji).

Authors:  Yueping Jiang; Min Liu; Haitao Liu; Shao Liu
Journal:  Phytochem Rev       Date:  2020-04-24       Impact factor: 5.374

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.